AAV vectors exploit the principles of nanotechnology to enhance gene delivery. Their small size (~25 nanometers) allows them to navigate through the extracellular matrix and cellular barriers. They can be engineered to target specific cells, tissues, or organs, making them potent tools for precision medicine. By manipulating the capsid proteins, researchers can direct AAV vectors to desired locations within the body, thereby optimizing therapeutic outcomes.
